FDA panel votes in favor of two anti-infective drugs
WASHINGTON (Reuters) - A panel of advisers to the U.S. Food and Drug Administration gave favorable reviews on Monday to two new medications to treat acute bacterial skin infections. The...
All Stories
U.S. FDA approves Biogen’s hemophilia B drug Alprolix
(Reuters) - Biogen Idec Inc has won U.S. approval for its long-acting hemophilia B treatment Alprolix, the U.S. Food and Drug Administration said on Friday. Hemophilia B is a rare,...
U.S. FDA approves Biogen’s hemophilia B drug Alprolix
(Reuters) - Biogen Idec Inc has won U.S. approval for its long-acting hemophilia B treatment Alprolix, the U.S. Food and Drug Administration said on Friday. Hemophilia B is a rare,...
FDA panel votes against Novartis drug for acute heart failure
(Reuters) - A drug made by Novartis AG to treat acute heart failure should not be approved because there is insufficient evidence it improves symptoms, a panel of advisers to...
FDA panel votes against Novartis drug for acute heart failure
(Reuters) - A drug made by Novartis AG to treat acute heart failure should not be approved because there is insufficient evidence it improves symptoms, a panel of advisers to...
U.S. teens’ e-cigarette use associated with smoking: study
WASHINGTON (Reuters) - A study published on Thursday found an association between smoking and e-cigarette use among adolescents but didn't answer a pressing public-health question on whether e-cigarettes acted as...
U.S. teens’ e-cigarette use associated with smoking: study
WASHINGTON (Reuters) - A study published on Thursday found an association between smoking and e-cigarette use among adolescents but didn't answer a pressing public-health question on whether e-cigarettes acted as...
Generic drugmakers ramp up campaign against FDA label proposal
WASHINGTON (Reuters) - Generic drugmakers are furiously campaigning against a proposed U.S. rule that would require them to change the prescribing information on their products if they receive new safety...
Generic drugmakers ramp up campaign against FDA label proposal
WASHINGTON (Reuters) - Generic drugmakers are furiously campaigning against a proposed U.S. rule that would require them to change the prescribing information on their products if they receive new safety...
U.S. proposes major update to food labels in bid to combat obesity
WASHINGTON (Reuters) - Packaged foods sold in the United States would display calorie counts more prominently and include the amount of added sugar under a proposal to significantly update nutritional...